Clinics in Laboratory Medicine

Papers
(The median citation count of Clinics in Laboratory Medicine is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Strategic Leadership in Laboratory Medicine: Navigating Belonging, Resilience, and Organizational Culture26
Forthcoming Issues17
Promoting Health Equity Through Effective Laboratory Stewardship Strategies16
Contributors15
Current Topics in Molecular Diagnostics and Precision Medicine15
Treatment Considerations of Myelodysplastic Syndromes/Neoplasms for Pathologists14
Digital Imaging and AI Pre-classification in Hematology12
Advances in Hemostasis Laboratory Testing11
Molecular Pathology of Ovarian Epithelial Neoplasms11
Molecular Detection of Oncogenic Gene Rearrangements11
Leadership's Role in Paving the Path to Diversity, Equity, and Inclusion in Laboratory Medicine10
Is It Possible to Test for Viral Infectiousness?10
Automated Quality Assurance Rules for Liquid Chromatography–Mass Spectrometry Testing in a Clinical Laboratory10
Point-of-Care Drug Testing10
Contributors10
Molecular Oncology Diagnostics10
Inclusive Laboratory Reference Intervals and Clinical Studies to Reduce Health Disparities9
Flow Cytometry-based Immune Phenotyping of T and B Lymphocytes in the Evaluation of Immunodeficiency and Immune Dysregulation9
Copy Number Analysis in Cancer Diagnostic Testing9
Contributors8
Flow Cytometry in Diagnosis, Prognostication, and Monitoring of Multiple Myeloma and Related Disorders8
Opportunities and Challenges with Artificial Intelligence in Genomics8
Contributors8
Leadership Approaches for Work-Life Balance, Well-Being, and Diversity, Equity, and Inclusion Support in the Laboratory8
Artificial Intelligence for Clinical Flow Cytometry7
Contents7
Cell-free Nucleic Acids in Cancer7
Contextualizing Race and Ethnicity in the Practice of Laboratory Medicine7
Diagnosis and Classification of Myelodysplastic Syndromes with Mutated TP537
Diagnostic Stewardship for Next-Generation Sequencing Assays in Clinical Microbiology7
Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing7
Nothing Basic About It: Guiding the Judicious Use of Diagnostic Tests7
Copyright6
Contents6
An Overview of SARS-CoV-2 Molecular Diagnostics in Europe6
Flow Cytometry and Platelets6
Molecular Diagnostics for Invasive Molds: From Lab to Bedside5
Transfusion Medicine: Renovation, Innovation, and Evolution5
Updates on Von Willebrand Disease Testing5
Steps Forward to a Fair and Inclusive Blood Supply5
Molecular Alterations in Pediatric Solid Tumors5
Implementation of Viscoelastic Testing at the Point of Care5
The Role of Artificial Intelligence in Transfusion Medicine5
Copyright5
The Evolving Role of Molecular Diagnostics in Pathology5
Electronic Health Record Optimization for Artificial Intelligence5
Updates in Antiphospholipid Syndrome Laboratory Diagnosis5
Molecular Biomarkers of Response to Cancer Immunotherapy5
Morphologic Characteristics of Myelodysplastic Syndromes5
The Impact of Inclusive Excellence Initiatives on Laboratory Wellness5
Expanding the Blood Donor Pool5
The Mass Spectrometry Revolution in Clinical Microbiology Part 24
Utility of Single-Gene Testing in Cancer Specimens4
Review of Established and Emerging Infectious Diseases in Transfusion Medicine4
Hemostatic Disorders Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection, COVID-19 Vaccination, and Long-COVID Syndrome4
Premalignant Clonal Hematopoiesis (Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenia of Undetermined Significance)4
Taking Center Stage4
Rapid Antigen Assays for SARS-CoV-24
Platelet Laboratory Testing: Integration of Molecular Testing and Advanced Methods4
Artificial Intelligence in the Clinical Laboratory4
Point of Care Molecular Testing4
von Willebrand Disease and von Willebrand Factor4
Copyright4
Flow Cytometric Assessment of Myelodysplastic Syndromes/Neoplasms3
Childhood Myelodysplastic Syndrome3
Molecular Pathology of Breast Tumors3
Copyright3
Influence of Race Modifiers in Estimated Glomerular Filtration Rate Calculations on Medication Dosing, Access, and Transplant Eligibility3
Copyright3
Performance of Non-nasopharyngeal Sample Types for Molecular Detection of SARS-CoV-23
Molecular Methods3
Bacterial Risk Mitigation Strategies for Platelets3
Value of Improving Result Interpretation in Direct-to-Definitive Urine Drug Panels3
Analytical Principles of Cancer Next Generation Sequencing3
Contents3
Contents3
Viscoelastic Testing for the Laboratorian3
Contributors3
An Overview of Common Donor and Therapeutic Apheresis Procedures3
Pathology Clinics Can Address Pathology Burnout3
A Winding Road to Health Care Equity in Sickle Cell Disease3
Diagnostic Stewardship for Multiplex Respiratory Testing3
A Meta-analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Anti-spike Immunoglobulin G Antibody Durability up to 9 Months After Full Vaccination in Adults3
Update on Ovarian Sex Cord–Stromal Tumors3
Point-of-Care Testing for the Diagnosis of Fungal Infections2
Current Topics in Molecular Diagnostics and Precision Medicine2
Contents2
Affirmative Healthcare for Transgender and Gender Nonconforming Patients2
Promoting Gender Equality in Pathology and Laboratory Medicine Leadership2
Flow Cytometric Assessment of Malignant Hematologic Disorders2
Implementation of the Individual Risk Assessment and Changes to Deferral Periods Since 20202
Cycle Threshold Values from Severe Acute Respiratory Syndrome Coronavirus-2 Reverse Transcription-Polymerase Chain Reaction Assays2
Artificial Intelligence in the Genetic Diagnosis of Rare Disease2
Racism in Drug Testing2
Clinical Cytometry for Platelets and Platelet Disorders2
System-Wide Leadership2
Molecular Pathology of Prostate Cancer2
Copyright2
Reshaping Organizational Culture in Pathology2
Patient Blood Management and Blood Product Alternatives2
Contributors2
History, Advances, and Challenges of Sickle Cell Disease Treatment2
Diagnosing Chagas in Pregnancy and Childhood2
Copyright2
Pathogen-Reduce Cryoprecipitate2
Specimen Validity Testing in the Toxicology Laboratory2
Forthcoming Issues2
Utility of Flow Cytometry Analysis in the Detection of Nonhematologic Neoplasms2
Covid-19 Molecular Testing and Clinical Correlates1
Forthcoming Issues1
Contents1
Molecular Pathology of Myeloid Neoplasms1
The Advancement of Infectious Diseases Diagnostics1
Contents1
The Role of the Human Gutome on Chronic Disease1
Epidemiology and Diagnosis of Lyme Disease in the United States1
Forthcoming Issues1
Advances in Clinical Mass Cytometry1
Diagnostics Stewardship in Molecular Microbiology: From at-home Testing to Next-Generation Sequencing1
Addressing Health Disparities in Clinical Pathology and Laboratory Medicine1
Hematology Laboratory in the Digital and Automation Age1
Forthcoming Issues1
Best Practice for Clinical Somatic Variant Interpretation and Reporting1
Diagnosis of Tick-Borne Diseases in New England1
Contributors1
Leadership Development for Pathology and Laboratory Medicine Residents and Fellows1
Approaches to Deployment of Molecular Testing for SARS-CoV-2 in Resource-Limited Settings1
Detection of Fentanyl and Fentanyl Analogs1
Optimizing Therapeutic Drug Monitoring of Anti-infectives1
Utility of Fluorescence In Situ Hybridization in Clinical and Research Applications1
Will Antigen Testing Remain Relevant in the Point-of-Care Testing Environment?1
Contributors1
Interpreting Toxicology Results in Perinatal and Newborn Specimens1
Myelodysplastic Syndromes1
Laboratory Aspects of Minimal / Measurable Residual Disease Testing in B-Lymphoblastic Leukemia1
Contents1
Molecular Testing Expansion and Utilization in Transfusion Medicine1
Copyright1
Molecular Approach to Colorectal Carcinoma1
SARS-CoV-2 Molecular Diagnostics in China1
Reflexive Drug Testing Strategies for Efficient Utilization of Resources and Better Interpretation1
Kidney Tumors1
Transfusion Support of Patients with Myelodysplastic Syndromes1
The Immunophenotypic Profile of Healthy Human Bone Marrow1
Advances and Progress in Automated Urine Analyzers1
Specimen Considerations in Molecular Oncology Testing1
Practical Considerations for Implementing Targeted Mass Spectrometry for Urine Drug Testing in Clinical Laboratories1
Carbapenemase Mechanism Testing to Support Treatment, Infection Control, and Public Health0
Contents0
Advances in Acute Myeloid Leukemia Classification, Prognostication and Monitoring by Flow Cytometry0
Infectious Diseases Diagnostics: From Current Strategies to Future Technologies0
How to Design and Validate a Clinical Flow Cytometry Assay0
Home and Clinical Laboratory Improvement Amendments–Waived Testing for Infectious Diseases—How Do These Fit in the Testing Landscape?0
Precision Medicine Using Pharmacogenomic Panel-Testing0
Contributors0
Pediatric Toxicology0
Advances in Flow Cytometry for Mixed Phenotype and Ambiguous Leukemias0
Opportunities and Drawbacks of Digitalized Morphologic Analysis of Body Fluids0
Contents0
Forthcoming Issues0
Molecular Techniques and Gene Mutations in Myelodysplastic Syndromes0
Advances in Monitoring and Prognostication for Lymphoma by Flow Cytometry0
Quality Assurance in Platelet Function Testing0
Copyright0
Metaplastic Breast Carcinoma Revisited; Subtypes Determine Outcomes0
Advances in Hemophilia: New Treatments and Complications in Laboratory Testing/Monitoring0
Practical Challenges of Point-of-Care Testing0
Thrombin Generation Assay0
Clinical Flow Cytometry Analysis in the Setting of Chronic Myeloid Neoplasms and Clonal Hematopoiesis0
Untargeted Mass Spectrometry Applications for Clinical Toxicology0
Novel Clinical and Laboratory Correlations for Antiphospholipid Syndrome0
Special Considerations in the Molecular Diagnostics of Pediatric Neoplasms0
Contents0
Contributors0
Building, Promoting and Maintaining a Culture of Psychological Safety and Resilience in the Laboratory0
Copyright0
Next-Generation Sequencing Approaches to Predicting Antimicrobial Susceptibility Testing Results0
Herpes B Virus0
Disaster Preparedness0
Laboratory Informatics Approaches to Improving Care for Gender- Diverse Patients0
Replacement of Culture with Molecular Testing for Diagnosis Infectious Diseases0
The Medical Practice of Molecular Oncology Diagnostics0
Strategies for Scaling up SARS-CoV-2 Molecular Testing Capacity0
Candida auris Diagnostics0
A Review of the Flow Cytometric Findings in Classic Hodgkin Lymphoma, Nodular Lymphocyte Predominant Hodgkin Lymphoma and T Cell/Histiocyte-Rich Large B Cell Lymphoma0
Preface0
Forthcoming Issues0
Copyright0
Molecular Pathology of Gastroesophageal Cancer0
Assessing Direct Oral Anticoagulants in the Clinical Laboratory0
The Successes and Challenges of SARS-CoV-2 Molecular Testing in the United States0
Molecular Pathology of Lung Cancer0
Copyright0
Applications of Noninvasive Prenatal Testing for Subchromosomal Copy Number Variations Using Cell-Free DNA0
Forthcoming Issues0
Pan-Cancer Molecular Biomarkers0
Practical Recommendations for Harmonization of Hemostasis Testing Across Hospital Sites0
Automation in Flow Cytometry0
Evolving Approach to Clinical Cytometry for Immunodeficiencies and Other Immune Disorders0
Current Trends in Identification and Susceptibility Testing of Mycobacteria0
Special Hematology Laboratory Testing: Emerging Concepts and Novel Approaches0
Advances in Bone Marrow Evaluation0
Artificial Intelligence Applications in Clinical Chemistry0
Syndromic and Point-of-Care Molecular Testing0
Advances in Myelodysplastic Syndromes0
Advances in Clinical Toxicology Testing0
Forthcoming Issues0
Pharmacologic Factor XI/XIa Inhibitors0
Literacy and Language Barriers to Overcome in Laboratory Medicine0
Machine Learning and Artificial Intelligence-Based Clinical Decision Support for Modern Hematology0
Contents0
Clinical Artificial Intelligence0
The Role of Point-of-Care Testing in Specific Populations0
High-throughput Sequencing in the Diagnosis of Inherited Bleeding and Clotting Disorders0
Molecular Diagnostic Testing for Hematopoietic Neoplasms0
Disseminated Intravascular Coagulation and Advances in D-Dimer Testing0
Using Artificial Intelligence to Better Predict and Develop Biomarkers0
Advances in Clinical Toxicology Testing0
Copyright0
Molecular Pathology of Gliomas0
Advances in Chromatography-Free and Ambient Ionization Mass Spectrometry Techniques Toward Clinical Toxicology Testing0
Contributors0
A Tale of Trial and Triumph: Molecular Diagnostics for Severe Acute Respiratory Coronavirus 2 Over the First Two Years of the Coronavirus Disease 2019 Pandemic0
Access Barriers in Testing for Sexually Transmitted Infections across Gender and Sexual Identities0
Copyright0
Advances in Hematology Analyzers Technology0
Copyright0
Contents0
A New Landscape of Testing and Therapeutics in Metastatic Breast Cancer0
Regulatory Approach to Point-of-Care/At-Home Testing in the United States0
Emerging Considerations in Transfusion Medicine0
Molecular Pathology of Urothelial Carcinoma0
Molecular Pathology of Thyroid Tumors0
Recent Advances in Therapeutic Drug Monitoring of Antineoplastic and Antimicrobial Agents in Children0
Significance of SF3B1 Mutations in Myeloid Neoplasms0
Artificial Intelligence in the Clinical Laboratory0
The Essential Role of Leadership in Laboratory Medicine0
Present and Future Non-Culture-Based Diagnostics: Stewardship Potentials and Considerations0
Review of SARS-CoV-2 Antigen and Antibody Testing in Diagnosis and Community Surveillance0
Acute Myeloid Leukemia Arising from Myelodysplastic Syndromes0
Testing Strategies and the Emergence of Designer Benzodiazepines0
The Enduring and Expanding Importance of Clinical Cytometry0
Working with the Electronic Health Record and Laboratory Information System to Maximize Ordering and Reporting of Molecular Microbiology Results0
When Tissue Is the Issue0
Best Practices in Thrombophilia Testing0
Women’s and Transgender Issues in Thrombosis and Hemostasis0
Advances in Hemostasis Laboratory Testing0
Contributors0
Forthcoming Issues0
Germline Testing for the Evaluation of Hereditary Cancer Predisposition0
1.2661919593811